scispace - formally typeset
Open AccessJournal ArticleDOI

Human Campylobacteriosis in Developing Countries1

Reads0
Chats0
TLDR
This work presents the distinguishing epidemiologic and clinical features of Campylobacter enteritis in developing countries relative to developed countries and suggests national surveillance programs and international collaborations are needed to address the substantial gaps in the knowledge about the epidemiology of campylobacteriaiosis in developing nations.
Abstract
Campylobacteriosis is a collective description for infectious diseases caused by members of the bacterial genus Campylobacter. The only form of campylobacteriosis of major public health importance is Campylobacter enteritis due to C. jejuni and C. coli. Research and control efforts on the disease have been conducted more often in developed countries than developing countries. However, because of the increasing incidence, expanding spectrum of infections, potential of HIV-related deaths due to Campylobacter, and the availability of the complete genome sequence of C. jejuni NCTC 11168, interest in campylobacteriosis research and control in developing countries is growing. We present the distinguishing epidemiologic and clinical features of Campylobacter enteritis in developing countries relative to developed countries. National surveillance programs and international collaborations are needed to address the substantial gaps in the knowledge about the epidemiology of campylobacteriosis in developing countries. ampylobacteriosis is a collective description for infectious diseases caused by members of the bacterial genus Campylobacter. The only form of campylobacteriosis of major public health importance is Campylobacter enteritis due to C. jejuni and C. coli (1). The rate of Campylobacter infections worldwide has been increasing, with the number of cases often exceeding those of salmonellosis and shigellosis (2). This increase, as well as the expanding spectrum of diseases caused by the organisms, necessitates a clearer understanding of the epidemiology and control of campylobacteriosis. Surveillance and control of diseases of public health

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae.

TL;DR: It is demonstrated that host-mediated inflammation in response to an infecting agent, a chemical trigger, or genetic predisposition markedly alters the colonic microbial community.
Journal ArticleDOI

Campylobacter jejuni : molecular biology and pathogenesis

TL;DR: C. jejuni establishes persistent, benign infections in chickens and is rapidly cleared by many strains of laboratory mouse, but causes significant inflammation and enteritis in humans.
Book

Domestic Wastewater Treatment in Developing Countries

Duncan Mara
TL;DR: What is Domestic Wastewater and Why Treat It and how is it used?
Journal ArticleDOI

Campylobacter, from obscurity to celebrity

TL;DR: In industrialised countries, the incidence of C. jejuni/Campylobacter coli infections peaks during infancy, and again in young adults aged 15-44 years, while in developing countries, inadequately treated water and contact with farm animals are the most important risk factors.
Journal ArticleDOI

Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation

TL;DR: A pathophysiologic scenario involving chronic and sustained stimulation of the immune system leading to lymphoid transformation has emerged and defines a distinct category of infection-associated lymphoid malignancies, in which the infectious agent does not directly infect and transform lymphoid cells, but rather indirectly increases the probability of lymphoids transformation by chronically stimulating theimmune system to maintain a protracted proliferative state.
References
More filters
Book

The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020.

TL;DR: This is the first in a planned series of 10 volumes that will attempt to "summarize epidemiological knowledge about all major conditions and most risk factors" and use historical trends in main determinants to project mortality and disease burden forward to 2020.
Journal ArticleDOI

Campylobacter jejuni—An Emerging Foodborne Pathogen

TL;DR: M Mishandling of raw poultry and consumption of undercooked poultry are the major risk factors for human campylobacteriosis, and efforts to prevent human illness are needed throughout each link in the food chain.
Journal ArticleDOI

Quinolone and Macrolide Resistance in Campylobacter jejuni and C. coli: Resistance Mechanisms and Trends in Human Isolates

TL;DR: Susceptibility data suggest that erythromycin and other macrolides should remain the drugs of choice in most regions, with systematic surveillance and control measures maintained, but fluoroquinolones may now be of limited use in the empiric treatment of Campylobacter infections in many regions.
Related Papers (5)